VERNAL KERATOCONJUNCTIVITIS;

Supratarsal injection of triamcinolone

Abstract

Purpose: To find out safety and effectiveness of supratarsal injection of Triamcinolone in cobble stone papilla e in Vernal
Keratoconjunctivitis (VKC). Design: Prospective, uncontrolled trial. Period: June 2009 to January 2010. Setting: Department of
Ophthalmology KMU Institute Of Medical Sciences Hospital KDA Kohat. Material and Methods: One hundred and fifty diagnosed patients
of VKC, of both sexes and age group between 5 – 40 years were included in the study. Patients with glaucoma, or steroid responder, postherpetic
corneal scar, active infection of cornea or conjunctiva, tightly closed eyelids, patients who lost follow-up, and patients unwilling
to be enrolled in this study were excluded from the study. The patients were enrolled and informed consent was taken. Supratarsal
injection of Triamcinolone was given. Their record was maintained and all the patients were followed up for six months for evaluating their
effectiveness and side effects. Results: We treated two hundred and seventy five eyes of one hundred fifty patients. Among them 80%
were males. Mean age was 14 years (range: 5—40 years). All of the patients had itching of eyes, redness, watering, photophobia,
cobble-stone papillae and Tranta's dots. Mean duration of disease was 27 weeks (Range: 4 weeks to 10 months). Patients were followed
up and multiple injections were given for controlling disease. Transient redness was the most common side effect of injection therapy.
Study shows 100% effectiveness of supratarsal injection of triamcinolone acetonide in VKC although